Skip to content

Embecta Corp. EMBC Intangible assets — net

Intangible assets — net at other companies

Insulet logo
InsuletPODD
ICU Medical logo
ICU MedicalICUI
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s intangible assets — net?
Embecta Corp. (EMBC) reported intangible assets — net of $6.5M in Q1 2026.
How has Embecta Corp.'s intangible assets — net changed year-over-year?
Embecta Corp.'s intangible assets — net decreased by 14.5% year-over-year, from $7.6M to $6.5M.
What is the long-term trend for Embecta Corp.'s intangible assets — net?
Over 4 years (2021 to 2025), Embecta Corp.'s intangible assets — net has grown at a -21.4% compound annual growth rate (CAGR), from $18.3M to $7M.